Woodrow Timothy Duncan, MD | |
1301 W 12th Ave Ste 202, Emporia, KS 66801-2589 | |
(620) 342-2900 | |
Not Available |
Full Name | Woodrow Timothy Duncan |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 28 Years |
Location | 1301 W 12th Ave Ste 202, Emporia, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508811241 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 0428175 (Kansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Angels Care Home Health | Wichita, KS | Home health agency |
Home Town Health Care Llc | Fredonia, KS | Home health agency |
Hand In Hand Hospice | Emporia, KS | Hospice |
Mother's Touch Home Health & Hospice Inc | Wichita, KS | Hospice |
Newman Regional Health | Emporia, KS | Hospital |
University Of Kansas Hospital | Kansas city, KS | Hospital |
Holiday Resort | Emporia, KS | Nursing home |
Flint Hills Care And Rehabilitation Center | Emporia, KS | Nursing home |
Emporia Presbyterian Manor | Emporia, KS | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells.
Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.
Stroke patients who received electrical brain stimulation coupled with swallowing exercises showed greater improvement in swallowing ability than patients who did not receive this stimulation, according to a pilot study reported in Stroke: Journal of the American Heart Association.
New proposals to reduce the risk of anaesthetic tubing becoming blocked during operations, were published today. Following 11 similar NHS cases where tubing had become blocked, the Chief Medical Officer, Sir Liam Donaldson set up an Expert Group in July 2002 to look into the issue.
› Verified 1 days ago
Entity Name | Cotton O'neil Clinic Revocable Trust |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells.
Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.
Stroke patients who received electrical brain stimulation coupled with swallowing exercises showed greater improvement in swallowing ability than patients who did not receive this stimulation, according to a pilot study reported in Stroke: Journal of the American Heart Association.
New proposals to reduce the risk of anaesthetic tubing becoming blocked during operations, were published today. Following 11 similar NHS cases where tubing had become blocked, the Chief Medical Officer, Sir Liam Donaldson set up an Expert Group in July 2002 to look into the issue.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Woodrow Timothy Duncan, MD 1301 W 12th Ave Ste 202, Emporia, KS 66801-2589 Ph: (620) 342-2900 | Woodrow Timothy Duncan, MD 1301 W 12th Ave Ste 202, Emporia, KS 66801-2589 Ph: (620) 342-2900 |
News Archive
Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells.
Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.
Stroke patients who received electrical brain stimulation coupled with swallowing exercises showed greater improvement in swallowing ability than patients who did not receive this stimulation, according to a pilot study reported in Stroke: Journal of the American Heart Association.
New proposals to reduce the risk of anaesthetic tubing becoming blocked during operations, were published today. Following 11 similar NHS cases where tubing had become blocked, the Chief Medical Officer, Sir Liam Donaldson set up an Expert Group in July 2002 to look into the issue.
› Verified 1 days ago
Roger W Roberts, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1301 W 12th Ave Ste 301, Emporia, KS 66801 Phone: 620-343-2376 | |
Chester W Stone, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 W 12th Ave, Emporia, KS 66801 Phone: 620-342-1117 Fax: 320-342-1185 | |
Michael F Lloyd, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 W 12th Ave Ste 207, Emporia, KS 66801 Phone: 620-343-6800 | |
Rachel Anne Duncan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 W 12th Ave Ste 202, Emporia, KS 66801 Phone: 620-342-2521 | |
Dr. Jonathan Charles Bates, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1301 W 12th Ave Ste 301, Emporia, KS 66801 Phone: 620-343-2376 Fax: 620-343-5987 | |
William Brock Kretsinger, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 W 12th Ave, Emporia, KS 66801 Phone: 620-342-2900 | |
Charisse Nicole Symmonds, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 W 12th Ave Ste 202, Emporia, KS 66801 Phone: 620-342-2521 Fax: 620-342-6520 |